Talphera Inc
R5XA
Company Profile
Business description
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Contact
1850 Gateway Drive
Suite 175
San MateoCA94404
USAT: +1 650 216-3500
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
13
Stocks News & Analysis
stocks
After slump this ASX share may be an opportunity
Lower than expected guidance led to a sell-off.
stocks
Investment decisions in overvalued bank drive strong results
Shares fall despite a broadly unchanged outlook.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,111.60 | 40.60 | -0.44% |
| CAC 40 | 8,055.51 | 105.33 | 1.32% |
| DAX 40 | 23,959.99 | 390.03 | 1.65% |
| Dow JONES (US) | 47,368.63 | 381.53 | 0.81% |
| FTSE 100 | 9,787.15 | 104.58 | 1.08% |
| HKSE | 26,715.26 | 66.20 | 0.25% |
| NASDAQ | 23,527.17 | 522.64 | 2.27% |
| Nikkei 225 | 51,229.51 | 317.75 | 0.62% |
| NZX 50 Index | 13,544.64 | 72.84 | -0.53% |
| S&P 500 | 6,832.43 | 103.63 | 1.54% |
| S&P/ASX 200 | 8,832.00 | 43.60 | -0.49% |
| SSE Composite Index | 4,012.60 | 6.00 | -0.15% |